FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation

Sep.18.2024
FirstUnion unveiled groundbreaking Alkaid technology at InterTabac, promising revolutionary changes in heat-not-burn smoking experience.

On September 19, at the InterTabac trade fair in Dortmund, Germany, FirstUnion was awarded the 2024 Alternative Awards for "Best HNB Innovation" for its groundbreaking Alkaid Light Heating Technology. This highly prestigious award highlights the revolutionary nature of Alkaid technology in the heated tobacco products (HNB) sector.

 

FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation
Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation | Image source:FirstUnion


That same evening, FirstUnion hosted an exclusive launch event at the world’s premier tobacco industry exhibition, showcasing how Alkaid technology addresses key consumer concerns such as heating speed, flavor quality, device cleanliness, and health impacts.

 

At the heart of Alkaid is its light-heating method, which leverages full-spectrum light waves, mimicking the natural power of sunlight to deliver rapid and uniform heating. Dr. Zhu Bin, FirstUnion's Alkaid light-heating technical lead, highlighted this feat enables the device to preheat in just five seconds, transforming the smoking experience by eliminating long wait times and offering users instant satisfaction with a smooth, seamless draw.

 

FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation
Dr. Zhu Bin, Chief Technology Officer of Alkaid, introduces Alkaid's light heating technology |Image source:FirstUnion

 

FirstUnion's Groundbreaking Alkaid Light Heating Technology Wins the 2024 InterTabac Alternative Award for Best HNB Innovation
Dr. Zhu Bin, Chief Technology Officer of Alkaid, introduces Alkaid's light heating technology |Image source:FirstUnion

 

Alkaid's rapid heating is only the beginning. The technology delivers superior taste and health benefits that elevate the smoking experience far beyond current standards. Alkaid increases the nicotine release efficiency in aerosols by over 40%,and boosts total particulate matter (TPM) by 20%, delivering an experience that closely mimics traditional cigarettes. Simultaneously, it cuts harmful substance emissions by 20%, significantly reducing potential health risks. Thanks to its innovative non-contact heating design, Alkaid requires no cleaning, ensuring the device maintains consistent, fresh-tasting results even after 5,000 continuous uses.

 

The development of Alkaid technology is the result of four years of extensive research and thousands of experiments conducted by a multidisciplinary team of more than 100 experts in materials science, optics, electronics, and tobacco. Drawing inspiration from solar collectors, Alkaid overcomes the limitations of traditional heating methods by utilizing the speed and penetrating power of light—a revolutionary concept poised to change the future of HNB.

 

FirstUnion has been committed to driving innovation in HNB technology, exploring this field since 2012 and launching several HNB products that have been well-received by the market. The release of Alkaid not only signifies FirstUnion’s continuous leadership at the forefront of the industry but also paves a new path for the global HNB sector.

 

As the tobacco industry moves further toward harm reduction, Alkaid’s unparalleled combination of innovation, practicality, and health benefits places it in prime position to disrupt the market. FirstUnion's commitment to creating better, safer alternatives for consumers is clear, and the introduction of Alkaid marks a bold step forward. As their release theme proudly declares: "Harnessing the power of light to guide the future—Alkaid brings the future within reach."

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Hunan China Tobacco Industry files heated tobacco device patent featuring adult-user identification through pressure sensing
Hunan China Tobacco Industry files heated tobacco device patent featuring adult-user identification through pressure sensing
China-based Hunan China Tobacco Industry Co., Ltd. and Shenzhen Baisha Technology Co., Ltd. have filed a patent application covering an adult-user identification mechanism for heated tobacco devices. The patent proposes using flexible pressure sensors installed in the device grip area to collect pressure distribution patterns generated when users hold the device. The system evaluates factors including effective contact area, grip shape and contact duration, and combines roller movement detection to determine whether unlocking conditions are met. The filing reflects exploration of device-level user recognition and smarter interaction technologies for heated tobacco products (HTPs).
Aug.05
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
At InterTabac 2026 in Dortmund, China Tobacco International (HK) Company Limited (CTIHK) is exhibiting across two separate booths in Hall 5 and Hall 4. Products observed by 2Firsts include heated tobacco products, nicotine pouches, Chinese cigars and tobacco leaf. Nicotine pouch products on display include TOOP, Shuangxi and Ashima.
Market
Sep.16
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
According to Reuters, citing Bloomberg News, British tobacco company Imperial Brands PLC plans to cut thousands of jobs across the United States and Europe as part of a cost reduction and organizational restructuring effort. The announcement drew market attention to the company’s shares. The move comes as global tobacco companies continue adjusting their operations amid slower cigarette market growth, changing consumer preferences and the transition toward next-generation nicotine products.
Aug.11